PharmTech Drug Digest 11.20
News|Articles|August 17, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-09-02-2015
  • Volume 11
  • Issue 9

Source BioScience Completes Acquisition of Select Pharma Laboratories

With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical testing services.

Source BioScience announced that it has completed its acquisition of Select Pharma Laboratories, a provider of stability storage and testing services to the pharmaceutical, animal health, and medical devices sectors.

Based in Stirling, Scotland, Select’s portfolio of laboratory services includes chemistry, physical, and microbiological analyses for application in therapeutics batch release and product release to the EU market. Select operates from GMP-accredited facilities, and holds accreditations with the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA).

With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical testing services.

Nick Ash, CEO of Source BioScience said in a press statement, “The acquisition of Select will provide the company with the expertise and capability to provide stability testing services that are highly complementary to the group’s existing stability storage services. Significant cross-selling opportunities are apparent with our existing customer base, enabling them to reduce the number of service providers and de-risk the process by avoiding unnecessary sample transfers.”

Source: Source BioScience

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.